Skip to content

Effects of Serotonin Agonist Buspirone on Multimodal Esophageal Stimulation in Healthy Volunteers

Effects of Serotonin Agonist Buspirone on Multimodal Esophageal Stimulation in Healthy Volunteers

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04352686
Enrollment
10
Registered
2020-04-20
Start date
2012-02-29
Completion date
2012-11-30
Last updated
2020-04-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gastroesophageal Reflux

Brief summary

To investigate if buspirone, a partial 5-HT-1A receptor agonist, is able to modify esophageal sensitivity, assessed by the multimodal stimulation.

Interventions

DRUGBuspirone

Administration of buspirone to assess esophageal sensitivity

DRUGPlacebo

Administration of placebo to assess differences in esophageal sensitivity

Sponsors

Universitaire Ziekenhuizen KU Leuven
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
OTHER
Masking
DOUBLE (Subject, Caregiver)

Eligibility

Sex/Gender
ALL
Age
18 Years to 60 Years
Healthy volunteers
Yes

Inclusion criteria

* HV aged between 18 - 60 years

Exclusion criteria

* history of psychiatric disease or a positive first degree psychiatric family history * pregnancy or lactation * concomitant administration of any centrally activating medication (anti-depressive medication, hypnotics, sedatives, anxiolytics, …) * medication affecting esophageal motility * significant co-morbidities (neuromuscular, psychiatric, cardiovascular, pulmonary, endocrine, autoimmune, renal and hepatic) * prior history of esophageal, gastric surgery or endoscopic anti-reflux procedure * history of gastrointestinal disease

Design outcomes

Primary

MeasureTime frameDescription
Change in sensitivity to thermal stimulationAfter 30 minutes after administration buspironeTo detect changes in thermal stimulation for sensitivity

Secondary

MeasureTime frameDescription
Change in sensitivity to mechanical stimulationAfter 45 minutes after administration buspironeTo detect changes in mechanical stimulation for sensitivity
Change in sensitivity to electrical stimulationAfter 60 minutes after administration buspironeTo detect changes in electrical stimulation for sensitivity
Change in sensitivity to chemical stimulationAfter 75 minutes after administration buspironeTo detect changes in chemical stimulation for sensitivity
Change in positive and negative affect scoreAt the beginning of the study and at the end of the multimodal stimulationto detect change in affect of the multimodal stimulation
Change in state trait and anxiety scoreAt the beginning of the study and at the end of the multimodal stimulationto detect changes in the score due to the multimodal stimulation

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026